YAP1 and breast carcinoma: To identify specific invadopodia-associated components that are affected by YAP and TAZ suppression, we conducted proteomic and transcriptomic profiling of MDA-MB-231 breast cancer cells, that demonstrated the most prominent enhancement of invadopodia following YAP/TAZ depletion.